Review Article

Treatment Strategies of Adult Primary Focal Segmental Glomerulosclerosis: A Systematic Review Focusing on the Last Two Decades

Table 1


First authorYearDesignStudyCountryPREDTACCSAMMFAZANoCRPRNRPR (BL)PR (FU)RL (%)FU (m)

Rydel [5]1995RetroCohortUSA10000301231513.6 ± 106762
Ponticelli [6]1999RetroCohortItaly100005321102225.8
Choi [7]2002RetroCohortUSA00010103254.5 ± 3.12.6 ± 2.97.9
Duncan [8]2004ProCohortUK01000606011 ± 4.52.8 ± 2.5012.8
Goumenos [9]2006RetroCohortUK/Greece10000853
Goumenos [9]2006RetroCohortUK/Greece10100761
Goumenos [9]2006RetroCohortUK/Greece10001541
Senthil Nayagam [10]2008ProRCTIndia1001017102533.315.3
Senthil Nayagam [10]2008ProRCTIndia100001692527.316.2
Jafry [11]2012RetroCohortEgypt1000079364396 ± 4.44.6 ± 5.13526

AZA: azathioprine, CR: complete remission, CSA: cyclosporine A, FU: follow-up, MMF: mycophenolate mofetil, No: number, NR: no remission, PRED: prednisone/prednisolone, PR: partial remission, PR (BL): proteinuria baseline, PR (FU): proteinuria follow-up, Pro: prospective, Retro: retrospective, RL: relapse, and TAC: tacrolimus.